The New York Times @nytimes
This is a time of great promise for Americans with sickle cell disease, who are mostly Black. But the hope is shadowed by a legacy of underinvestment in sickle-cell treatments compared with diseases that mostly afflict white people, research has shown. https://t.co/rRxFwemuku — PolitiTweet.org